Dosidal · Switzerland

Sarclisa, solution à diluer pour perfusion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:67525 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 67525
atc: L01FC02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2020-03-18
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01FC02
authorisation_number: 67525
form: KOINF
holder: Sanofi-Aventis (Suisse) SA
holder_partner_nr: 1005874
it_number: 07.16.1.
name: Sarclisa, solution à diluer pour perfusion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
2oLQ4GWqUZu0Hexj05P7RsgHIM28Ny7SmfsfhM_xCYjr6QGcjG9Y7Ystl3JUtnwxjt1oZpvAyZHhNoxv2t8dhA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:67525 · Related records in other markets · Dosidal